Paradigm Biocapital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001855655 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value: $3.516B (100.0% shares, 0.0% debt)

Holdings (36)

NUVL NUVALENT INC 13.0%
Value $456M Shares 5,269,433 Est. Cost $60.72 Unrealized +30.2%
MERUS N V 11.7%
Value $412M Shares 4,373,770 Est. Cost $51.34 Unrealized
ACLX ARCELLX INC 10.9%
Value $382M Shares 4,649,016 Est. Cost $41.59 Unrealized +73.1%
RVMD REVOLUTION MEDICINES INC 8.3%
Value $291M Shares 6,223,291 Est. Cost $36.52 Unrealized +7.2%
TARS TARSUS PHARMACEUTICALS INC 4.5%
Value $158M Shares 2,665,698 Est. Cost $28.61 Unrealized +72.1%
PCVX VAXCYTE INC 3.9%
Value $136M Shares 3,784,755 Est. Cost $56.25 Unrealized -41.1%
ABVX ABIVAX SA 3.8%
Value $133M Shares 1,564,196 Est. Cost $84.90 Unrealized
GMAB GENMAB A/S 3.3%
Value $117M Shares 3,816,851 Est. Cost $30.67 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 3.1%
Value $107M Shares 2,673,555 Est. Cost $34.49 Unrealized +9.0%
CRNX CRINETICS PHARMACEUTICALS IN 3.0%
Value $106M Shares 2,550,774 Est. Cost $26.84 Unrealized +19.1%
XBI SPDR SERIES TRUST 2.8%
Value $100M Shares 1,000,000 Est. Cost Unrealized
EWTX EDGEWISE THERAPEUTICS INC 2.8%
Value $100M Shares 6,170,131 Est. Cost $20.10 Unrealized -29.4%
CIDARA THERAPEUTICS INC 2.6%
Value $92.04M Shares 961,164 Est. Cost $95.76 Unrealized
URGN UROGEN PHARMA LTD 2.4%
Value $84.11M Shares 4,216,084 Est. Cost $17.96 Unrealized 0.0%
SRRK SCHOLAR ROCK HLDG CORP 2.1%
Value $74.84M Shares 2,009,745 Est. Cost $32.12 Unrealized +8.9%
JANX JANUX THERAPEUTICS INC 2.0%
Value $71.37M Shares 2,920,258 Est. Cost $48.02 Unrealized -49.3%
OLMA OLEMA PHARMACEUTICALS INC 1.9%
Value $66.51M Shares 6,794,172 Est. Cost $8.25 Unrealized -27.2%
APGE APOGEE THERAPEUTICS INC 1.7%
Value $60.46M Shares 1,521,757 Est. Cost $44.51 Unrealized -14.2%
VRDN VIRIDIAN THERAPEUTICS INC 1.6%
Value $56.31M Shares 2,609,353 Est. Cost $17.86 Unrealized +1.0%
ALKS ALKERMES PLC 1.5%
Value $51.58M Shares 1,719,334 Est. Cost $29.45 Unrealized -4.2%
LENZ LENZ THERAPEUTICS INC 1.4%
Value $50M Shares 1,073,461 Est. Cost $27.56 Unrealized +33.4%
PHVS PHARVARIS N V 1.3%
Value $45.8M Shares 1,835,494 Est. Cost $18.67 Unrealized +18.8%
COGT COGENT BIOSCIENCES INC 1.3%
Value $45.33M Shares 3,156,398 Est. Cost $7.69 Unrealized +54.1%
OCUL OCULAR THERAPEUTIX INC 1.2%
Value $40.88M Shares 3,497,307 Est. Cost $7.86 Unrealized +52.0%
BBIO BRIDGEBIO PHARMA INC 1.0%
Value $35.54M Shares 684,277 Est. Cost $36.37 Unrealized +34.1%
ERAS ERASCA INC 0.8%
Value $29.56M Shares 13,560,017 Est. Cost $2.19 Unrealized -27.4%
EYPT EYEPOINT PHARMACEUTICALS INC 0.8%
Value $28.56M Shares 2,005,365 Est. Cost $11.51 Unrealized 0.0%
MERUS N V 0.8%
Value $28.25M Shares 300,000 Est. Cost $51.34 Unrealized
TNGX TANGO THERAPEUTICS INC 0.7%
Value $25.92M Shares 3,086,184 Est. Cost $6.77 Unrealized 0.0%
AMLX AMYLYX PHARMACEUTICALS INC 0.7%
Value $25.82M Shares 1,900,000 Est. Cost $9.41 Unrealized 0.0%
SYRE SPYRE THERAPEUTICS INC 0.7%
Value $24.59M Shares 1,467,266 Est. Cost $26.04 Unrealized -37.4%
DYN DYNE THERAPEUTICS INC 0.7%
Value $24.02M Shares 1,898,950 Est. Cost $11.41 Unrealized 0.0%
BBOT BRIDGEBIO ONCOLOGY THERAPEUT 0.6%
Value $21.61M Shares 1,866,141 Est. Cost $11.58 Unrealized
IRON DISC MEDICINE INC 0.5%
Value $16.37M Shares 247,716 Est. Cost $48.64 Unrealized +22.3%
GPCR STRUCTURE THERAPEUTICS INC 0.3%
Value $10.44M Shares 372,869 Est. Cost $28.00 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 0.2%
Value $8.028M Shares 200,000 Est. Cost $34.49 Unrealized +9.0%